Disclosures: This work was supported by grant K12HD063086 from the National Institutes of
Health (NIH), Bethesda, Maryland. The contents of this work are the responsibility of the …

Background Women with polycystic ovary syndrome (PCOS) are almost three times more
likely to be obese than those without PCOS. However, we have no specific interventions to …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

The efficacy of metformin for the treatment of obesity has been evaluated in few clinical trials
with inconclusive results. Moreover, the effectiveness in a real-life outpatient setting has not …

Obesity is a chronic disease with increasing prevalence. It affects quality of life and renders
those affected at increased risk of mortality. For people living with obesity, weight loss is one …

Metformin, a synthetic biguanide, is currently one of the most frequently recommended
medications for type 2 diabetes treatment around the world. This review presents the latest …

Aims The aim of this study was to assess the effects of orlistat on weight loss‐related clinical
variables in overweight/obese women with polycystic ovary syndrome (PCOS) and to …

Objective To provide a comprehensive review and evidence-based recommendations for
the delivery of fertility care to women with obesity. Outcomes The impact of obesity on …

BACKGROUND: The effects of exercise, metformin, and orlistat on anthropometric
parameters, lipid profile, endocrine parameters, and ovulation in polycystic ovarian …

OBJECTIVE: The current study intends to find out the efficacy of Orlistat in the management
of hyperlipidemia, Systolic Blood Pressure (SBP) and Body Mass Index (BMI). MATERIALS …